[ad_1]
AbbVie inventory slipped on Friday after the pharma large reported adjusted earnings of $3.66 per share on $14.81 billion in third-quarter gross sales.
X
On common, analysts polled by FactSet anticipated AbbVie (ABBV) to earn $3.57 per share on $14.96 billion in gross sales. The corporate famous “short-term financial headwinds” hamstrung its aesthetics division, together with Botox face-filler and wrinkle-fighter Juvederm.
Within the year-earlier interval, AbbVie earned $2.83 per share on $14.34 billion in gross sales.
For the 12 months, AbbVie narrowed its earnings outlook to $13.84-$13.88 per share, however saved the identical midpoint. The corporate did not supply gross sales steering. AbbVie inventory analysts forecasted adjusted revenue of $13.85 per share and $58.92 billion in gross sales.
In premarket buying and selling on right now’s inventory market, AbbVie inventory skidded 3.3%, buying and selling close to 148.40.
Extra to observe.
Comply with Allison Gatlin on Twitter at @IBD_AGatlin.
YOU MAY ALSO LIKE:
Merck Surges Inside Purchase Zone As Two Key Merchandise Drive Its Bullish Report
Why Pandemic Darlings Teladoc, Align Diverged On Their Third-Quarter Stories
Choices Buying and selling: How To Begin Utilizing Choices, How To Handle Threat
Comply with Premarket And After-The-Open Motion With IBD Specialists
Shares To Purchase And Watch: Prime IPOs, Large And Small Caps, Progress Shares
[ad_2]
Source link